Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group

[1]  W. Haverkamp,et al.  Cost‐Effectiveness of Paclitaxel‐Coated Balloon Angioplasty in Patients With Drug‐Eluting Stent Restenosis , 2013, Clinical cardiology.

[2]  J. Wöhrle,et al.  Paclitaxel‐coated balloon with bare‐metal stenting in patients with chronic total occlusions in native coronary arteries , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[3]  A. Kastrati,et al.  Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial , 2013, The Lancet.

[4]  A. Colombo,et al.  A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study. , 2012, Journal of the American College of Cardiology.

[5]  T. Albrecht,et al.  Paclitaxel-Coated Balloons Reduce Restenosis After Femoro-Popliteal Angioplasty: Evidence From the Randomized PACIFIER Trial , 2012, Circulation. Cardiovascular interventions.

[6]  P. Stella,et al.  A multicenter randomized comparison of drug‐eluting balloon plus bare‐metal stent versus bare‐metal stent versus drug‐eluting stent in bifurcation lesions treated with a single‐stenting technique: Six‐month angiographic and 12‐month clinical results of the drug‐eluting balloon in bifurcations trial , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[7]  P. Barragan,et al.  SeQuentPlease World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study. , 2012, Journal of the American College of Cardiology.

[8]  P. Stella,et al.  One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic Argentina Registry (DEAR). , 2012, Cardiovascular revascularization medicine : including molecular interventions.

[9]  R. Tölg,et al.  Twelve-month results of a paclitaxel releasing balloon in patients presenting with in-stent restenosis First-in-Man (PEPPER) trial. , 2012, Cardiovascular revascularization medicine : including molecular interventions.

[10]  J. Harnek,et al.  Comparison of two drug-eluting balloons: a report from the SCAAR registry. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[11]  Á. Cequier,et al.  Implantation of a drug-eluting stent with a different drug (switch strategy) in patients with drug-eluting stent restenosis. Results from a prospective multicenter study (RIBS III [Restenosis Intra-Stent: Balloon Angioplasty Versus Drug-Eluting Stent]). , 2012, JACC. Cardiovascular interventions.

[12]  M. Böhm,et al.  Drug coated balloons in acute coronary syndromes--opportunities and limitations. , 2012, Current vascular pharmacology.

[13]  P. Stella,et al.  First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-mont , 2012, Journal of the American College of Cardiology.

[14]  R. Waksman.  Too early to call. , 2012, Cardiovascular revascularization medicine : including molecular interventions.

[15]  J. Brachmann,et al.  A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. , 2012, Journal of the American College of Cardiology.

[16]  P. Serruys,et al.  Very Late Coronary Stent Thrombosis of a Newer-Generation Everolimus-Eluting Stent Compared With Early-Generation Drug-Eluting Stents: A Prospective Cohort Study , 2012, Circulation.

[17]  P. Teirstein,et al.  Five-year follow-up of the Sirolimus-Eluting Stents vs Vascular Brachytherapy for Bare Metal In-Stent Restenosis (SISR) trial. , 2012, American heart journal.

[18]  M. Böhm,et al.  Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. , 2012, JACC. Cardiovascular interventions.

[19]  W. Haverkamp,et al.  Cost-effectiveness of paclitaxel-coated balloon angioplasty and paclitaxel-eluting stent implantation for treatment of coronary in-stent restenosis in patients with stable coronary artery disease , 2012, Clinical Research in Cardiology.

[20]  A. Íñiguez,et al.  One-year outcomes with angiographic follow-up of paclitaxel-eluting balloon for the treatment of in-stent restenosis: insights from Spanish multicenter registry. , 2011, Journal of interventional cardiology.

[21]  H. Bäzner,et al.  Neurovascular In-Stent Stenoses: Treatment with Conventional and Drug-Eluting Balloons , 2011, American Journal of Neuroradiology.

[22]  S. Silber,et al.  The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[23]  P. Serruys,et al.  Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[24]  D. Scheinert,et al.  First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. , 2011, Journal of the American College of Cardiology.

[25]  W. Rottbauer,et al.  Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease , 2011, Heart.

[26]  B. Scheller.  Opportunities and limitations of drug-coated balloons in interventional therapies , 2011, Herz.

[27]  M. Boxberger,et al.  Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[28]  W. Desmet,et al.  Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[29]  D. Mathey,et al.  How to use the drug-eluting balloon: recommendations by the German consensus group. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[30]  P. Serruys,et al.  New technologies in percutaneous coronary interventions: drug-coated balloons. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[31]  H. Ackermann,et al.  Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[32]  C. Danzer,et al.  A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rational , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[33]  T. Maruo,et al.  Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. , 2011, JACC. Cardiovascular interventions.

[34]  Matti Niemelä,et al.  Simple or Complex Stenting for Bifurcation Coronary Lesions: A Patient-Level Pooled-Analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study , 2011, Circulation. Cardiovascular interventions.

[35]  Bernard Chevalier,et al.  Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. , 2011, Journal of the American College of Cardiology.

[36]  M. Böhm,et al.  Treatment of coronary in-stent restenosis with a novel paclitaxel urea coated balloon. , 2010, Minerva cardioangiologica.

[37]  Volkmar Falk,et al.  Guidelines on myocardial revascularization. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[38]  William Wijns,et al.  Experience with revascularization procedures does matter: low volume means worse outcome. , 2010, European heart journal.

[39]  B. Cortese,et al.  Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO Study , 2010, Heart.

[40]  A. Kastrati,et al.  Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study. , 2010, Journal of the American College of Cardiology.

[41]  H. Ackermann,et al.  Treatment of small coronary arteries with a paclitaxel-coated balloon catheter , 2010, Clinical Research in Cardiology.

[42]  Ralf Degenhardt,et al.  Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the Treatment of Coronary In-Stent Restenosis , 2009, Circulation.

[43]  Renu Virmani,et al.  One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis. , 2009, JACC. Cardiovascular imaging.

[44]  M. Niemelä,et al.  Randomized Comparison of Coronary Bifurcation Stenting With the Crush Versus the Culotte Technique Using Sirolimus Eluting Stents: The Nordic Stent Technique Study , 2009, Circulation. Cardiovascular interventions.

[45]  B. Hamm,et al.  Inhibition of Restenosis in Femoropopliteal Arteries: Paclitaxel-Coated Versus Uncoated Balloon: Femoral Paclitaxel Randomized Pilot Trial , 2008, Circulation.

[46]  M. Böhm,et al.  Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter , 2008, Clinical Research in Cardiology.

[47]  P. Stella,et al.  Safety and efficacy of drug‐eluting balloons in percutaneous treatment of bifurcation lesions the DEBIUT (drug‐eluting balloon in bifurcaton utrecht) registry , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[48]  C. Claussen,et al.  Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. , 2008, The New England journal of medicine.

[49]  M. Pfisterer,et al.  Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET). , 2007, European heart journal.

[50]  D. Desilvey.  Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. , 2007, The American journal of geriatric cardiology.

[51]  M. Niemelä,et al.  Randomized Study on Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions: The Nordic Bifurcation Study , 2006, Circulation.

[52]  Michael Joner,et al.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.

[53]  P. Serruys,et al.  Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials. , 2005, European heart journal.

[54]  A. Kastrati,et al.  Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. , 2005, JAMA.

[55]  M. Böhm,et al.  Paclitaxel Balloon Coating, a Novel Method for Prevention and Therapy of Restenosis , 2004, Circulation.

[56]  Fernando Alfonso,et al.  Coronary stenting versus balloon angioplasty in small vessels: a meta-analysis from 11 randomized studies. , 2004, Journal of the American College of Cardiology.

[57]  D. Holmes,et al.  Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty. , 2004, American heart journal.

[58]  G. Rosano,et al.  Short- and long-term evolution of unstented nonocclusive coronary dissection after coronary angioplasty. , 1999, Journal of the American College of Cardiology.

[59]  M. Leon,et al.  Intracoronary radiation for patients with refractory in-stent restenosis: an analysis from the WRIST-Crossover Trial. Washington Radiation for In-stent Restenosis Trial. , 1999, Cardiovascular radiation medicine.

[60]  S. Pocock,et al.  A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. , 1999, The New England journal of medicine.

[61]  S. Pocock,et al.  A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting , 1998 .

[62]  P Hall,et al.  Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. , 1995, Circulation.

[63]  P. Teirstein,et al.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.

[64]  W Rutsch,et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[65]  J. Deckers,et al.  Therapeutic dissection after successful coronary balloon angioplasty: no influence on restenosis or on clinical outcome in 693 patients. The MERCATOR Study Group (Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis). , 1992, Journal of the American College of Cardiology.

[66]  M. Mooney,et al.  Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. , 1991, The American journal of cardiology.

[67]  U. Sigwart,et al.  Emergency stenting for acute occlusion after coronary balloon angioplasty. , 1988, Circulation.

[68]  S. Ellis,et al.  Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. , 1988, Circulation.

[69]  F Joffre,et al.  Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. , 1987, The New England journal of medicine.

[70]  J. Douglas,et al.  Influence of intimal dissection on restenosis after successful coronary angioplasty. , 1985, Circulation.

[71]  A. Grüntzig.  TRANSLUMINAL DILATATION OF CORONARY-ARTERY STENOSIS , 1978, The Lancet.

[72]  Orchard Tj.  Letter: Mobile coronary care. , 1974 .

[73]  P. Agostoni,et al.  Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET). , 2007, European heart journal.

[74]  Ousa,et al.  A RANDOMIZED COMPARISON OF A SIROLIMUS-ELUTING STENT WITH A STANDARD STENT FOR CORONARY REVASCULARIZATION , 2002 .